ResCure Pharma

Preventing Breast Cancer Recurrence

Health Tech & Life Sciences
Non Active, Aug 2018
Pre-Funding Haifa, Israel Founded 2015
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2015
Headcount
6
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences

About

ResCure Pharma is developing novel platform technology for discovery and development of therapies for breast cancer recurrence. Approximately 20% of breast cancer patients are at risk of breast cancer recurrence 5-20 years after initial treatment. Recurrence can occur locally (in the treated breast or near the mastectomy scar) or appear as a metastatic disease in distant organs. To date there is no treatment to eradicate metastatic disease. Therefore, it is essential to develop new therapeutic approaches to confront metastatic disease before it emerges. ResCure is in the process of initial validation of potential compounds discovered by the company for the prevention and treatment of metastatic breast cancer recurrence.

Q&A

What is ResCure Pharma's primary focus?
ResCure Pharma is focused on developing novel platform technology for the discovery and development of therapies to prevent breast cancer recurrence.
What is the current status of ResCure Pharma?
ResCure Pharma is currently inactive as of August 2018.
When was ResCure Pharma founded?
ResCure Pharma was founded in March 2015.
Where is ResCure Pharma headquartered?
ResCure Pharma is headquartered in Haifa, Israel.
How many employees did ResCure Pharma have?
ResCure Pharma had 1-10 employees.
Who is the Scientific Founder of ResCure Pharma?
Dalit Barkan is the Scientific Founder of ResCure Pharma.
What is ResCure Pharma's current funding stage?
ResCure Pharma is in the Pre-Funding stage.
What is the company's product stage?
ResCure Pharma's product is in the R&D stage.

Team · 1

Founder · Scientific Founder
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business model
B2B

Tags

pharma-companiespatientscancerpatent-pendingmedical-technologiestreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2015-3
Employees (exact)6
Status reasonNon Active, Aug 2018